CURIS INC business relationships
Companies named in CURIS INC’s 10-K filed 2026-03-24, and public companies whose annual reports name CURIS INC. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 72 / 100 Top 1% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in CURIS INC’s annual report 5
“The Company was party to a collaboration agreement (the "Genentech License Agreement") with Genentech Inc. ("Genentech"), a member of the Roche Group, under which Genentech and F.” SEC filing
“The Company's former customer, Genentech, accounted for 100 % of the total gross revenues for the years ended December 31, 2025 and 2024.” SEC filing
“The Company sold to the Purchasers a portion of its rights to receive royalties from Genentech on potential net sales of Erivedge.” SEC filing
“The Company was party to a collaboration agreement (the "Genentech License Agreement") with Genentech Inc. ("Genentech"), a member of the Roche Group, under which Genentech and F.” SEC filing
“However, a significant portion of our royalty and royalty-related revenues under our collaboration with Genentech was paid to the Purchasers, pursuant to the Oberland Purchase Agreement.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.